Editorial: Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses

Yong Tang; Patrizia Rubini; Beata Sperlagh; Henning Ulrich

doi:10.3389/fphar.2023.1355286

Editorial: Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses

Front Pharmacol. 2024 Jan 12:14:1355286. doi: 10.3389/fphar.2023.1355286. eCollection 2023.

Authors

Yong Tang^{1

2}, Patrizia Rubini¹, Beata Sperlagh³, Henning Ulrich^{1

4}

Affiliations

¹ International Joint Research Centre on Purinergic Signalling, Chengdu, China.
² Acupuncture and Chronobiology Key Laboratory of Sichuan Province, School of Health and Rehabilitation, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
³ Laboratory of Molecular Pharmacology, HUN-REN Institute of Experimental Medicine, Budapest, Hungary.
⁴ Department of Biochemistry, Institute of Chemistry, University of Sao Paulo, Sao Paulo, Brazil.

No abstract available

Keywords: ATP; P1; P2; adenosine; central nervous system; neurological and psychiatric illnesses; purinergic signalling.

Publication types

Editorial

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. NSFC-RSF (82261138557), NSFC (82274668, 82230127), the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine (ZYYCXTD-D-202003), the Sichuan Science and Technology Program (2022YFH0006), Sichuan Provincial Administration of Traditional Chinese Medicine (2023zd024), the São Paulo Research Foundation (FAPESP 2018/07366-4), and National Council for Scientific and Technological Development (CNPq, Brasília) (406396/2021-3).